Lorenz Trümper

Overview

Best Publications

• CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

  Michael Pfreundschuh;Lorenz Trümper;Anders Österborg;Ruth Pettengell

  2901
  Citations

• Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

  Wolfgang Hiddemann;Michael Kneba;Martin Dreyling;Norbert Schmitz

  1928
  Citations

• Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

  Bjoern Chapuy;Chip Stewart;Andrew J Dunford;Jaegil Kim

  1919
  Citations

• The landscape of genomic alterations across childhood cancers

  Susanne N. Gröbner;Barbara C. Worst;Joachim Weischenfeldt;Joachim Weischenfeldt;Ivo Buchhalter

  1562
  Citations

• Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

  Michael Pfreundschuh;Joerg Schubert;Marita Ziepert;Rudolf Schmits

  1297
  Citations

• A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling

  Michael Hummel;Stefan Bentink;Hilmar Berger;Wolfram Klapper

  1173
  Citations

• Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

  Andreas Engert;Annette Plütschow;Hans Theodor Eich;Andreas Lohri

  1056
  Citations

• New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients.

  Detlef Haase;Ulrich Germing;Julie Schanz;Michael Pfeilstöcker

  1020
  Citations

• Patterns of somatic structural variation in human cancer genomes

  Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  942
  Citations

• CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.

  Michael Pfreundschuh;Evelyn Kuhnt;Lorenz Trümper;Anders Österborg

  901
  Citations

• Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL

  Michael Pfreundschuh;Lorenz Trümper;Marita Kloess;Rudolf Schmits

  863
  Citations

• Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.

  Norbert Schmitz;Lorenz Trümper;Marita Ziepert;Maike Nickelsen

  676
  Citations

• Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

  Steven Horwitz;Owen A O'Connor;Barbara Pro;Tim Illidge

  660
  Citations

• Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.

  Michael Pfreundschuh;Lorenz Trümper;Marita Kloess;Rudolf Schmits

  657
  Citations

• MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

  Heike Horn;Marita Ziepert;Claudia Becher;Thomas F. E. Barth

  639
  Citations

• Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study

  Andreas Engert;Volker Diehl;Jeremy Franklin;Andreas Lohri

  628
  Citations

• NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity

  Leszek Wojnowski;Bettina Kulle;Markus Schirmer;Gregor Schlüter

  558
  Citations

• Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-α dependent up-regulation of matrix metalloproteases

  Thorsten Hagemann;Stephen C. Robinson;Matthias Schulz;Lorenz Trümper

  526
  Citations

• Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing

  Julia Richter;Matthias Schlesner;Steve Hoffmann;Markus Kreuz

  474
  Citations

• From bench to bedside

  Lorenz Trümper

  0
  Citations